Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

fatro s.p.a., itālija - diklofenaka nātrija sāls - šķīdums injekcijām - 50 mg/ml - sporta zirgi

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

bioveta, a.s., Čehija - fipronils - šķīdums pilināšanai uz ādas - 50 mg - kaķi

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Latvija - latviešu - Zāļu valsts aģentūra

casen recordati, s.l., spain - natrii picosulfas, magnesii oxidum leve, acidum citricum - pulveris iekšķīgi lietojama šķīduma pagatavošanai paciņā - 0,01 g/3,5 g/10,97 g

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 un 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 un 5.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - other nervous system drugs - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - rokuronija vai vekuronija izraisītas neiromuskulārās blokādes atsākšana. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neiromuskulārā blokāde - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.